doi: 10.1016/0305-7372(89)90026-1.
Immunotherapy with interleukin-2 by constant infusion with and without adoptive cell transfer and with weekly doxorubicin
Affiliations
- PMID: 2788508
- DOI: 10.1016/0305-7372(89)90026-1
Item in Clipboard
Immunotherapy with interleukin-2 by constant infusion with and without adoptive cell transfer and with weekly doxorubicin
Cancer Treat Rev.
1989 Jun.
No abstract available
Similar articles
-
Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies.Cancer Treat Rev. 1989 Jun;16 Suppl A:83-9. doi: 10.1016/0305-7372(89)90027-3. Cancer Treat Rev. 1989. PMID: 2788509 No abstract available.
-
High dose-intense chemotherapy alone or in combination with interleukin-2 for small cell lung cancer: a pilot study.Cancer Invest. 1994;12(6):574-87. doi: 10.3109/07357909409023042. Cancer Invest. 1994. PMID: 7994592 Clinical Trial.
-
Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study.Cancer Treat Rev. 1989 Jun;16 Suppl A:59-63. doi: 10.1016/0305-7372(89)90024-8. Cancer Treat Rev. 1989. PMID: 2788507 No abstract available.
-
Adoptive immunotherapy in the treatment of malignant disease.Transfusion. 1989 Feb;29(2):170-8. doi: 10.1046/j.1537-2995.1989.29289146838.x. Transfusion. 1989. PMID: 2645696 Review. No abstract available.
-
Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.Annu Rev Immunol. 1986;4:681-709. doi: 10.1146/annurev.iy.04.040186.003341. Annu Rev Immunol. 1986. PMID: 3518753 Review. No abstract available.
Cited by
-
Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancer.Cancer Immunol Immunother. 1992;34(6):424-6. doi: 10.1007/BF01741755. Cancer Immunol Immunother. 1992. PMID: 1532923 Free PMC article. Clinical Trial.
-
Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy.Br J Cancer. 1996 Feb;73(4):465-71. doi: 10.1038/bjc.1996.82. Br J Cancer. 1996. PMID: 8595160 Free PMC article.
-
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. Characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulation.Cancer Immunol Immunother. 1991;33(2):128-32. doi: 10.1007/BF01742541. Cancer Immunol Immunother. 1991. PMID: 2036660 Free PMC article. Clinical Trial.
-
Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy.Br J Cancer. 1993 Jan;67(1):163-71. doi: 10.1038/bjc.1993.29. Br J Cancer. 1993. PMID: 7678979 Free PMC article. Clinical Trial.
-
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.Drugs. 1993 Sep;46(3):446-514. doi: 10.2165/00003495-199346030-00009. Drugs. 1993. PMID: 7693434 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
